{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:44:25Z","timestamp":1790084665598,"version":"4.0.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Lipid-based markers have a profound prognostic potential concerning cardiovascular diseases. However, differences in lipid levels between women and men are evident, and it is unknown whether the differences also extend to the predictive power of the lipid markers. Therefore, this study aims to evaluate potential sex differences concerning the risk estimation of five topical lipid markers: low-density lipoprotein cholesterol (LDL-C), remnant cholesterol, apolipoprotein A-1 (ApoA-1), the triglyceride\/HDL cholesterol (TG\/HDL) ratio, and ceramide scores (CERT1 and CERT2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this prospective cohort study, the lipid markers were obtained for patients with high cardiovascular risk, who were followed for major cardiovascular events (MACE) for up to 14 years. The risk estimation was done for women (n = 433) and age-matched men (n = 433) separately using multiple performance and discrimination metrics. Women showed higher LDL-C and ApoA-1 and lower remnant cholesterol and TG\/HDL ratio. Also, CERT1, but not CERT2, differed between the sexes, with women scoring slightly higher. During follow-up, MACE occurred in 25% of women and 37% of men. While an adjusted Cox regression demonstrated that remnant cholesterol significantly predicted MACE in both sexes, the ApoA-1 and TG\/HDL ratio was a predictor only in women, whereas ceramide-based scores predicted MACE solely in men. LDL-C showed no predictive potential in this high-risk cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To estimate cardiovascular risk, in several cases, a sex-specific adaptation of lipid markers seems warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf646","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:05:43Z","timestamp":1759914343000},"page":"2354-2364","source":"Crossref","is-referenced-by-count":0,"title":["Sex-specific disparities in lipid-based prediction of major cardiovascular events"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-7186","authenticated-orcid":false,"given":"Laura","family":"Schnetzer","sequence":"first","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-4125","authenticated-orcid":false,"given":"Axel","family":"Muendlein","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]},{"name":"Faculty of Medical Sciences, Private University in the Principality of Liechtenstein , Triesen, Principality of Liechtenstein"},{"name":"Medical Central Laboratories , Feldkirch ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4278-2964","authenticated-orcid":false,"given":"Andreas","family":"Festa","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]},{"name":"Faculty of Medical Sciences, Private University in the Principality of Liechtenstein , Triesen, Principality of Liechtenstein"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4226-4982","authenticated-orcid":false,"given":"Christoph H","family":"Saely","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]},{"name":"Faculty of Medical Sciences, Private University in the Principality of Liechtenstein , Triesen, Principality of Liechtenstein"},{"name":"Medicine I, Academic Teaching Hospital Feldkirch , Feldkirch ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4677-9756","authenticated-orcid":false,"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]},{"name":"Faculty of Medical Sciences, Private University in the Principality of Liechtenstein , Triesen, Principality of Liechtenstein"},{"name":"Vorarlberger Landeskrankenhaus-Betriebsgesellschaft , Feldkirch ,","place":["Austria"]},{"name":"Drexel University College of Medicine , Philadelphia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-5704","authenticated-orcid":false,"given":"Andreas","family":"Leiherer","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) , Carinagasse 47, Feldkirch 6800 ,","place":["Austria"]},{"name":"Faculty of Medical Sciences, Private University in the Principality of Liechtenstein , Triesen, Principality of Liechtenstein"},{"name":"Medical Central Laboratories , Feldkirch ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"2026092119575261800_zwaf646-B1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/joim.13656","article-title":"Elevated low-density lipoprotein cholesterol: an inverse marker of morbidity and mortality in patients with myocardial infarction","volume":"294","author":"Schubert","year":"2023","journal-title":"J Intern Med"},{"key":"2026092119575261800_zwaf646-B2","doi-asserted-by":"crossref","first-page":"e024248","DOI":"10.1161\/JAHA.121.024248","article-title":"Low-density lipoprotein cholesterol attributable cardiovascular disease risk is sex specific","volume":"11","author":"Cupido","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026092119575261800_zwaf646-B3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/molecules25071506","article-title":"Sex-related differences of the effect of lipoproteins and apolipoproteins on 10-year cardiovascular disease risk; insights from the ATTICA study (2002\u20132012)","volume":"25","author":"Kouvari","year":"2020","journal-title":"Molecules"},{"key":"2026092119575261800_zwaf646-B4","doi-asserted-by":"crossref","first-page":"119048","DOI":"10.1016\/j.atherosclerosis.2024.119048","article-title":"Remnant cholesterol and long-term incidence of death in coronary artery disease patients","volume":"401","author":"Drexel","year":"2024","journal-title":"Atherosclerosis"},{"key":"2026092119575261800_zwaf646-B5","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2024.240826","article-title":"The different relevance of remnant cholesterol with gender and age compared to common cholesterol","volume":"71","author":"Cheng","year":"2025","journal-title":"Clin Lab"},{"key":"2026092119575261800_zwaf646-B6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.numecd.2007.02.010","article-title":"Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I\u2014new risk factors and targets for therapy","volume":"17","author":"Walldius","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026092119575261800_zwaf646-B7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","article-title":"Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data","volume":"22","author":"Che","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026092119575261800_zwaf646-B8","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"2026092119575261800_zwaf646-B9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"},{"key":"2026092119575261800_zwaf646-B10","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092119575261800_zwaf646-B11","doi-asserted-by":"crossref","first-page":"e027103","DOI":"10.1161\/JAHA.122.027103","article-title":"Lipidome- and genome-wide study to understand sex differences in circulatory lipids","volume":"11","author":"Tabassum","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026092119575261800_zwaf646-B12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"key":"2026092119575261800_zwaf646-B13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/dom.16084","article-title":"Three decades of glucose-lowering therapy in patients at high cardiovascular risk\u2014a real-world analysis","volume":"27","author":"Neyer","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026092119575261800_zwaf646-B14","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.3390\/jcm12196151","article-title":"Coronary event risk test (CERT) as a risk predictor for the 10-year clinical outcome of patients with peripheral artery disease","volume":"12","author":"Leiherer","year":"2023","journal-title":"J Clin Med"},{"key":"2026092119575261800_zwaf646-B15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/eurjpc\/zwab112","article-title":"Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients","volume":"29","author":"Leiherer","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119575261800_zwaf646-B16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"2026092119575261800_zwaf646-B17","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026092119575261800_zwaf646-B18","author":"Food and Drug Administration"},{"key":"2026092119575261800_zwaf646-B19","volume-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis Third Edition A Regression-Based Approach","author":"Hayes","year":"2022","edition":"3rd ed."},{"key":"2026092119575261800_zwaf646-B20","author":"Harrel"},{"key":"2026092119575261800_zwaf646-B21","author":"Therneau"},{"key":"2026092119575261800_zwaf646-B22","author":"Gerds"},{"key":"2026092119575261800_zwaf646-B23","doi-asserted-by":"crossref","first-page":"101340","DOI":"10.1016\/j.arr.2021.101340","article-title":"Changes in plasma phospholipids and sphingomyelins with aging in men and women: a comprehensive systematic review of longitudinal cohort studies","volume":"68","author":"Mohammadzadeh Honarvar","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2026092119575261800_zwaf646-B24","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European atherosclerosis society","volume":"44","author":"Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"},{"key":"2026092119575261800_zwaf646-B25","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/01.CIR.81.5.1498","article-title":"Body fat distribution and male\/female differences in lipids and lipoproteins","volume":"81","author":"Freedman","year":"1990","journal-title":"Circulation"},{"key":"2026092119575261800_zwaf646-B26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrcardio.2009.105","article-title":"Gender differences in the cardiovascular effect of sex hormones","volume":"6","author":"Vitale","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"2026092119575261800_zwaf646-B27","doi-asserted-by":"crossref","first-page":"117279","DOI":"10.1016\/j.atherosclerosis.2023.117279","article-title":"Sex differences in the genetic and molecular mechanisms of coronary artery disease","volume":"384","author":"Sakkers","year":"2023","journal-title":"Atherosclerosis"},{"key":"2026092119575261800_zwaf646-B28","doi-asserted-by":"crossref","first-page":"oeae001","DOI":"10.1093\/ehjopen\/oeae001","article-title":"Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol","volume":"4","author":"Leiherer","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2026092119575261800_zwaf646-B29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/clinchem\/hvae217","article-title":"Remnant cholesterol: quantification, concentrations by sex and age, and risk of ischemic heart disease","volume":"71","author":"Balling","year":"2024","journal-title":"Clin Chem"},{"key":"2026092119575261800_zwaf646-B30","doi-asserted-by":"crossref","first-page":"1415424","DOI":"10.3389\/fendo.2024.1415424","article-title":"Gender-specific correlations between remnant cholesterol and severe abdominal aortic calcification in American adults","volume":"15","author":"Yan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026092119575261800_zwaf646-B31","doi-asserted-by":"crossref","first-page":"63695","DOI":"10.5551\/jat.63695","article-title":"The association of remnant cholesterol with endothelial dysfunction and subclinical atherosclerosis in a check-up population in China","volume":"30","author":"Yang","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"2026092119575261800_zwaf646-B32","doi-asserted-by":"crossref","first-page":"e009442","DOI":"10.1161\/JAHA.118.009442","article-title":"Triglyceride and triglyceride\/HDL (high density lipoprotein) ratio predict Major adverse cardiovascular outcomes in women with non-obstructive coronary artery disease","volume":"8","author":"Prasad","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026092119575261800_zwaf646-B33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.numecd.2015.05.006","article-title":"Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis","volume":"25","author":"Wu","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026092119575261800_zwaf646-B34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/HJR.0b013e3283213140","article-title":"How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators","volume":"16","author":"Cooney","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026092119575261800_zwaf646-B35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/dom.16156","article-title":"Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study","volume":"27","author":"Mantovani","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026092119575261800_zwaf646-B36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"2026092119575261800_zwaf646-B37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-2362.2007.01888.x","article-title":"Assessing risk of myocardial infarction and stroke: new data from the prospective cardiovascular M\u00fcnster (PROCAM) study","volume":"37","author":"Assmann","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"2026092119575261800_zwaf646-B38","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"2026092119575261800_zwaf646-B39","doi-asserted-by":"crossref","first-page":"106633","DOI":"10.1016\/j.isci.2023.106633","article-title":"Overcoming cohort heterogeneity for the prediction of subclinical cardiovascular disease risk","volume":"26","author":"Chan","year":"2023","journal-title":"iScience"},{"key":"2026092119575261800_zwaf646-B40","doi-asserted-by":"crossref","first-page":"c2442","DOI":"10.1136\/bmj.c2442","article-title":"An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study","volume":"340","author":"Collins","year":"2010","journal-title":"BMJ"},{"key":"2026092119575261800_zwaf646-B41","doi-asserted-by":"crossref","first-page":"100709","DOI":"10.1016\/j.ajpc.2024.100709","article-title":"Sex-related differences in the 20-year incidence of CVD and its risk factors: the ATTICA study (2002\u20132022)","volume":"19","author":"Sigala","year":"2024","journal-title":"Am J Prev Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf646\/64544427\/zwaf646.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/13\/2354\/64544427\/zwaf646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/13\/2354\/64544427\/zwaf646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:58:02Z","timestamp":1790035082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/13\/2354\/8277371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":41,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf646","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2025,10,8]]}}}